Abstract | AIMS: We aim to determine the significant effect of TPEN, a Zn(2+) chelator, in mediating the pathophysiological cascade in neuron death/apoptosis induced by hypoxia/ ischemia. METHODS: We conducted both in vivo and in vitro experiments in this study. PC12 cells were used to establish hypoxia/ ischemia model by applying oxygen- glucose deprivation (OGD). SHR-SP rats were used to establish an acute ischemic model by electrocoagulating middle cerebral artery occlusion. The effect of TPEN on neuron death/apoptosis was evaluated. In addition, the relative biomarks of excitotoxicity, oxidative stress, and inflammation reactions in hypoxia/ ischemia PC12 cell model as well as in SHR-SP rat hypoxia/ ischemia model were also assessed. RESULTS:
TPEN significantly attenuates the neurological deficit, reduced the cerebral infarction area and the ratio of apoptotic neurons, and increased the expression of GluR2 in the rat hypoxia/ischemia brain. TPEN also increased blood SOD activity, decreased blood NOS activity and blood MDA and IL-6 contents in rats under hypoxia/ ischemia. In addition, TPEN significantly inhibited the death and apoptosis of cells and attenuated the alteration of GluR2 and NR2 expression caused by OGD or OGD plus high Zn(2+) treatments. CONCLUSIONS: Zn(2+) is involved in neural cell apoptosis and/or death caused by hypoxia/ ischemia via mediating excitotoxicity, oxidative stress, and inflammation.
|
Authors | Wei-Ming Wang, Zhao Liu, Ai-Jun Liu, Yu-Xiang Wang, Hong-Gang Wang, Di An, Bin Heng, Lai-Hua Xie, Jun-Li Duan, Yan-Qiang Liu |
Journal | CNS neuroscience & therapeutics
(CNS Neurosci Ther)
Vol. 21
Issue 9
Pg. 708-17
(Sep 2015)
ISSN: 1755-5949 [Electronic] England |
PMID | 26190227
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2015 John Wiley & Sons Ltd. |
Chemical References |
- Chelating Agents
- Ethylenediamines
- Neuroprotective Agents
- Receptors, AMPA
- Receptors, N-Methyl-D-Aspartate
- Glucose
- Zinc
- glutamate receptor ionotropic, AMPA 2
- N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine
|
Topics |
- Animals
- Apoptosis
(drug effects, physiology)
- Brain
(drug effects, pathology, physiopathology)
- Brain Ischemia
(drug therapy, pathology, physiopathology)
- Cell Hypoxia
(drug effects, physiology)
- Chelating Agents
(pharmacology)
- Disease Models, Animal
- Ethylenediamines
(pharmacology)
- Female
- Glucose
(deficiency)
- Infarction, Middle Cerebral Artery
- Ischemia
(drug therapy, pathology, physiopathology)
- Neuroimmunomodulation
(drug effects, physiology)
- Neurons
(drug effects, pathology, physiology)
- Neuroprotective Agents
(pharmacology)
- Oxidative Stress
(drug effects, physiology)
- PC12 Cells
- Rats
- Rats, Inbred SHR
- Receptors, AMPA
(metabolism)
- Receptors, N-Methyl-D-Aspartate
(metabolism)
- Zinc
(metabolism)
|